---
schema_version: "secwatch.filing_event.v1"
accession: "0001787306-22-000038"
form_type: "8-K"
ticker: "ARQT"
cik: "0001787306"
company_name: "Arcutis Biotherapeutics, Inc."
filed_at: "2022-06-02T23:59:59+00:00"
generated_at: "2026-06-25T05:11:59.088662+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Arcutis stockholders elect all three Class II directors and ratify Ernst & Young

## Summary
- Bhaskar Chaudhuri received 39.76M votes for, 3.83M withheld; Howard Welgus 30.92M for, 12.66M withheld; Sue-Jean Lin 39.09M for, 4.49M withheld.
- Ratification of Ernst & Young as independent auditor for FY 2022: 47.07M for, 48k against, 14k abstain.
- Non-binding advisory vote on executive compensation: 41.01M for, 2.07M against, 502k abstain.
- Advisory vote on frequency of say-on-pay: majority (43.40M votes) favored one year.
- About 51.4M shares outstanding and entitled to vote; broker non-votes were 3.55M on director and say-on-pay proposals.

## SEC filing metadata
- accession: 0001787306-22-000038
- form_type: 8-K
- ticker: ARQT
- cik: 0001787306
- company_name: Arcutis Biotherapeutics, Inc.
- filed_at: 2022-06-02T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1787306/000178730622000038/0001787306-22-000038-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1787306/000178730622000038/arqt-20220601.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001787306-22-000038
- JSON: https://secwatch.observer/filing/0001787306-22-000038.json
- Plain text: https://secwatch.observer/filing/0001787306-22-000038.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.